Skip to main content

Christopher Liu

Stock Analyst at Leerink Partners

Total Price Targets
4
Stocks Covered
4
Sectors
Healthcare
Most Recent
Nov 19, 2024

Stocks Covered by Christopher Liu

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
ARVNArvinas, Inc.$62.00$10.55+487.5%1Nov 19, 2024
EXELExelixis, Inc.$28.50$43.81-34.9%1Oct 16, 2024
NUVLNuvalent, Inc.$110.00$99.45+10.6%1Apr 1, 2024
COGTCogent Biosciences, Inc.$15.00$36.84-59.3%1Jun 10, 2022

Recent Activity

  • Nov 19, 2024— Set$62.00price target onARVN(Arvinas, Inc.)
  • Oct 16, 2024— Set$28.50price target onEXEL(Exelixis, Inc.)
  • Apr 1, 2024— Set$110.00price target onNUVL(Nuvalent, Inc.)
  • Jun 10, 2022— Set$15.00price target onCOGT(Cogent Biosciences, Inc.)

Frequently Asked Questions

Who is Christopher Liu?

Christopher Liu is a stock analyst at Leerink Partners covering 4 stocks primarily in Healthcare. They have issued 4 price targets since Jun 10, 2022.

What stocks does Christopher Liu cover?

Christopher Liu currently covers 4 stocks, including ARVN, EXEL, NUVL, COGT.

What is Christopher Liu's latest price target?

Christopher Liu's most recent price target was $62.00 on ARVN (Arvinas, Inc.), set on Nov 19, 2024.

What is Christopher Liu's highest price target?

Christopher Liu's highest issued price target is $110.00 on NUVL, set on Apr 1, 2024.

Coverage based on publicly published price targets. Not investment advice.